| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/22/1999 | WO1999019346A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
| 04/22/1999 | WO1999019320A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | WO1999019302A1 Pyridyl compounds and pharmaceutical compositions containing them |
| 04/22/1999 | WO1999018994A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018976A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | WO1999018962A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | WO1999018952A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 04/22/1999 | WO1999018949A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | WO1999018939A1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 04/22/1999 | WO1999018930A2 Pharmaceutical preparations |
| 04/22/1999 | WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof |
| 04/22/1999 | WO1999006035A3 COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | WO1999001118A3 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 04/22/1999 | WO1998050383A8 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 04/22/1999 | WO1998043618A9 Use of cytoskeletal inhibitors for the prevention of restenosis |
| 04/22/1999 | DE19847781A1 Pharmaceutical preparations containing PETN or metabolite useful in treatment of cardiac, circulatory, and cerebrovascular disorders |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2307929A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors |
| 04/22/1999 | CA2306823A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 04/22/1999 | CA2306789A1 Pyridyl compounds and pharmaceutical compositions containing them |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306276A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | CA2306228A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | CA2306206A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | CA2306096A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | CA2305499A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/21/1999 | EP0909820A2 Histidine kinase from Staphylococcus pneumoniae |
| 04/21/1999 | EP0885217A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0882039A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0793641B1 Metalloproteinase inhibitors |
| 04/21/1999 | CN1214694A Peptides with antiproliferative properties |
| 04/21/1999 | CN1214682A Eprosartan dihydrate and process for its production and formulation |
| 04/21/1999 | CN1214672A Dimethyl-substituted cyclohexane diene derivatives |
| 04/21/1999 | CN1214631A Use of rapamycin derivatives in vasculopathies and xenotransplantation |
| 04/21/1999 | CN1214629A Solid instant-release forms of administration and process for producing the same |
| 04/21/1999 | CN1214624A Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
| 04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018101A1 Benzothiophenes |
| 04/15/1999 | WO1999018096A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | WO1999018081A1 Substituted fused heterocyclic compounds |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999018070A1 Novel vitamin d analogues |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017784A1 Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| 04/15/1999 | WO1999017777A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | WO1999017775A1 QUINOLINE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017773A1 Compounds and methods |
| 04/15/1999 | WO1999017772A1 5ht4 agonists and antagonists |
| 04/15/1999 | WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | WO1999017769A1 INDENO[1,2-c]-, NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 04/15/1999 | WO1999017763A1 Postsurgical treatment with dichloroacetate |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999009025A3 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 04/15/1999 | WO1999004770A3 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 04/15/1999 | DE19811047C1 Copper-containing ribonucleoproteins |
| 04/15/1999 | DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives |
| 04/15/1999 | DE19745146A1 New N-acyl N-acyl-aminoethyl alpha-amino acid derivatives |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2306746A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | CA2306489A1 Benzothiophenes |
| 04/15/1999 | CA2306245A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy |
| 04/15/1999 | CA2305805A1 Compounds and methods |
| 04/15/1999 | CA2305726A1 Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2304826A1 5ht4 agonists and antagonists |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304565A1 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 04/15/1999 | CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/15/1999 | CA2304116A1 Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908459A1 5-HT4 Agonists and antagonists |
| 04/14/1999 | EP0908456A1 Pyrazole derivatives, their preparation and their use in drugs |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907644A1 Pharmaceutical preparation |
| 04/14/1999 | EP0907637A1 Phenylalamine derivatives as integrin inhibitors |
| 04/14/1999 | EP0907632A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 04/14/1999 | EP0907631A1 Inorganic ion receptor-active compounds |
| 04/14/1999 | EP0907369A1 Materials and methods for treatment of plaquing diseases |
| 04/14/1999 | EP0907318A1 Antioxidant compound |
| 04/14/1999 | EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0698010B1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 04/14/1999 | EP0626952B1 Hypolipidaemic benzothiazepine compounds |
| 04/14/1999 | EP0595924B1 Platelet activating factor antagonists |
| 04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
| 04/14/1999 | CN1214048A Benzopyran derivatives having leukotriene-antagonistic action |
| 04/14/1999 | CN1214043A Benzyl(idene)-lactam derivatives, their prepn. and their use as selective (ant) agaonists of 5-ht1A-and/or 5-ht1D receptors |
| 04/14/1999 | CN1213965A Use of antiarrhythmic compounds for reducing post-infarction morality |